57 related articles for article (PubMed ID: 6287268)
1. Cryopreservation of human peripheral blood lymphoid cells reactive to allogeneic antigens, virus-transformed autologous cells and autologous leukemia cells in in vitro sensitization.
Yamada H; Kodera Y; Yamada K
Nagoya J Med Sci; 1982 Mar; 44(3-4):117-31. PubMed ID: 6287268
[No Abstract] [Full Text] [Related]
2. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
Mori T; Koishi T; Fujii G; Ohsawa N
Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
[TBL] [Abstract][Full Text] [Related]
3. Characterization of alloantigen-activated human lymphocytes cytotoxic for autologous EB virus-transformed lymphoblastoid cell lines.
Zarling JM
Transplant Proc; 1981 Dec; 13(4):1893-6. PubMed ID: 6277059
[No Abstract] [Full Text] [Related]
4. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukemias and preleukemic disorders. I. Blocking activity of gp70 antigens of primate type C viruses.
Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
Neoplasma; 1983; 30(2):129-35. PubMed ID: 6302527
[TBL] [Abstract][Full Text] [Related]
5. [Antibody-dependent cytotoxicity of lymphocytes in acute myeloblastic leukemia and chronic myelocytic leukemia].
Tishchenko LM; Guseva SA
Eksp Onkol; 1987; 9(2):66-7. PubMed ID: 3472877
[TBL] [Abstract][Full Text] [Related]
6. [Agarose selection of human lymphoid cells transformed in vitro by Epstein-Barr virus].
Ragona G; Resta S; Andreoni M; Rocchi G
Ann Ist Super Sanita; 1982; 18(3):395-6. PubMed ID: 6320706
[No Abstract] [Full Text] [Related]
7. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
Wasik M; Matej H; Duś D; Myc A
Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
[TBL] [Abstract][Full Text] [Related]
8. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
9. In vitro induction of cytotoxic effector cells against human neoplasms. I. Sensitization conditions and effect of cryopreservation on the induction and expression of cytotoxic responses to allogeneic leukemia cells.
Kedar E; Raanan Z; Kafka I; Holland JF; Bekesi G; Weiss DW
J Immunol Methods; 1979; 28(3-4):303-19. PubMed ID: 383844
[TBL] [Abstract][Full Text] [Related]
10. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
[No Abstract] [Full Text] [Related]
11. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production.
Yarchoan R; Nelson DL
J Immunol; 1983 Sep; 131(3):1222-8. PubMed ID: 6309961
[TBL] [Abstract][Full Text] [Related]
12. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
Zarling JM; Bach FH; Kung PC
J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo generation of cytokine-induced killer cells (CD3+ CD56+) from post-stem cell transplant pediatric patients against autologous-Epstein-Barr virus-transformed lymphoblastoid cell lines.
Petvises S; Pakakasama S; Wongkajornsilp A; Sirireung S; Panthangkool W; Hongeng S
Pediatr Transplant; 2007 Aug; 11(5):511-7. PubMed ID: 17631019
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.
Meuer SC; Cooper DA; Hodgdon JC; Hussey RE; Morimoto C; Schlossman SF; Reinherz EL
J Immunol; 1983 Sep; 131(3):1167-72. PubMed ID: 6309959
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
Honda S; Takasaki T; Okuno K; Yasutomi M; Kurane I
Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
[TBL] [Abstract][Full Text] [Related]
17. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
Plotnicky H; Touraine JL
Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
[TBL] [Abstract][Full Text] [Related]
18. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
Wasik M; Myc A; Matej H; Rudzka L
Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
20. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
